Wood-AllumC., ShawP.J.Motor neurone disease: a practical update on diagnosis and management.Clin Med2010; 10(3): 252–258.
2.
LacomblezL., BensimonG., LeighP.N.Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.Lancet1996; 347(9013): 1425–1431.
3.
BensimonG., LacomblezL., MeiningerV.A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.N Engl J Med1994; 330(9): 585–591.
4.
BourkeS.C., O'NeillC.L., WilliamsT.L.The changing landscape of non-invasive ventilation in amyotrophic lateral sclerosis.J Neuro Neurosurg Psychiatry2012; 83(4): 368–369. doi: 10.1136/jnnp-2012-302253.
5.
OliverD., BorasioD., WalshD.Palliative care in amyotrophic lateral sclerosis from diagnosis to bereavement.2nd ed.New York: Oxford University Press; 2006.
6.
AounS.M., BentleyB., FunkL.A 10-year literature review of family caregiving for motor neurone disease: moving from caregiver burden studies to palliative care interventions.Palliat Med2013; 27(5): 437–446. doi: 10.1177/0269216312455729.
7.
DickieB.Defining the principles of palliative care in amy-otrophic lateral sclerosis.J Neuro Neurosurg Psychiatry2011; 82(4): 356. doi: 10.1136/jnnp.2010.239137.
8.
FoleyG., TimonenV., HardimanO.Acceptance and decision making in amyotrophic lateral sclerosis from a life-course perspective.Qual Health Res2014; 24(1): 67–77. doi: 10.1177/1049732313516545.
9.
WhiteheadB., O'BrienM.R., JackB.A.Experiences of dying, death and bereavement in motor neurone disease: a qualitative study.Palliat Med2012; 26(4): 368–378. doi: 10.1177/0269216311410900.
10.
HigginsonI.J., EvansC.J., GrandeG.Evaluating complex interventions in end of life care: the MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews.BMC Med2013; 11: 111. doi: 10.1186/1741-7015-11-111.
11.
PrestonN.J., FayersP., WaltersS.J.Recommendations for managing missing data, attrition and response shift in palliative and end-of-life care research: part of the MORECare research method guidance on statistical issues.Palliat Med2013; 27(10): 899–907. doi: 10.1177/0269216313486952.
12.
BaxterS.K., BairdW.O., ThompsonS.The use of non-invasive ventilation at end of life in patients with motor neurone disease: a qualitative exploration of family carer and health professional experiences.Palliat Med2013; 27(6): 516–523. doi: 10.1177/0269216313478449.
13.
Van den BergJ.P., de GrootI.J., JohaB.C.Development and implementation of the Dutch protocol for rehabilitative management in amyotrophic lateral sclerosis.Amyotroph Lateral Scler Other Motor Neuron Disord2004; 5(4): 226–229.
14.
BedeP., OliverD., StodartJ.Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives.J Neuro Neurosurg Psychiatry2011; 82(4): 413–418. doi: 10.1136/jnnp.2010.232637.
15.
GyselsM.H., EvansC., HigginsonI.J.Patient, caregiver, health professional and researcher views and experiences of participating in research at the end of life: a critical interpretive synthesis of the literature.BMC Med Res Methodol2012; 12: 123. doi: 10.1186/1471-2288-12-123.